1. Home
  2. FMS vs RGC Comparison

FMS vs RGC Comparison

Compare FMS & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMS
  • RGC
  • Stock Information
  • Founded
  • FMS 1996
  • RGC 2014
  • Country
  • FMS Germany
  • RGC Hong Kong
  • Employees
  • FMS 111513
  • RGC N/A
  • Industry
  • FMS Misc Health and Biotechnology Services
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • FMS Health Care
  • RGC Health Care
  • Exchange
  • FMS Nasdaq
  • RGC Nasdaq
  • Market Cap
  • FMS 13.8B
  • RGC N/A
  • IPO Year
  • FMS 1996
  • RGC 2021
  • Fundamental
  • Price
  • FMS $24.46
  • RGC $29.01
  • Analyst Decision
  • FMS Hold
  • RGC
  • Analyst Count
  • FMS 1
  • RGC 0
  • Target Price
  • FMS $25.00
  • RGC N/A
  • AVG Volume (30 Days)
  • FMS 428.6K
  • RGC 92.1K
  • Earning Date
  • FMS 05-06-2025
  • RGC 06-20-2025
  • Dividend Yield
  • FMS 2.59%
  • RGC N/A
  • EPS Growth
  • FMS 7.65
  • RGC N/A
  • EPS
  • FMS 1.89
  • RGC N/A
  • Revenue
  • FMS $20,018,541,263.00
  • RGC N/A
  • Revenue This Year
  • FMS $5.05
  • RGC N/A
  • Revenue Next Year
  • FMS $3.90
  • RGC N/A
  • P/E Ratio
  • FMS $25.68
  • RGC N/A
  • Revenue Growth
  • FMS N/A
  • RGC N/A
  • 52 Week Low
  • FMS $17.93
  • RGC $3.03
  • 52 Week High
  • FMS $25.96
  • RGC $69.00
  • Technical
  • Relative Strength Index (RSI)
  • FMS 52.98
  • RGC 51.71
  • Support Level
  • FMS $23.52
  • RGC $27.25
  • Resistance Level
  • FMS $24.32
  • RGC $31.52
  • Average True Range (ATR)
  • FMS 0.60
  • RGC 4.43
  • MACD
  • FMS -0.00
  • RGC -0.93
  • Stochastic Oscillator
  • FMS 76.51
  • RGC 23.44

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: